A Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Nebulized Bacteriophage Treatment in Outpatient Adult Cystic Fibrosis (CF) Subjects With Chronic Pseudomonas Aeruginosa (PsA) Pulmonary Infection
Latest Information Update: 04 Aug 2025
At a glance
- Drugs BX 004 (Primary)
- Indications Pseudomonal infections
- Focus Adverse reactions; First in man; Proof of concept
- Sponsors BiomX
Most Recent Events
- 18 Jul 2025 Status changed from active, no longer recruiting to completed.
- 08 Jul 2025 Results presented in the BiomX Media Release
- 08 Jul 2025 According to a BiomX media release, data from this trial published at Nature Communications.